Physician profile
Hamid Abdollahi
NPI 1467640565
$3,265.68
in general payments reported to CMS, 2019-2025
14 companies · $769 in 2025
The $769 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.56 · 2020: $730 · 2021: $568 · 2022: $724 · 2023: $301 · 2024: $119 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,506.07 | 2019-2025 | |
| Integra Lifesciences Corporation | $436.65 | 2021-2025 | Integra, Surgimend, Omnigraft |
| Mentor Worldwide LLC | $278.23 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $269.26 | 2021-2022 | |
| Allergan, INC. | $168.75 | 2020-2022 | |
| Rti Surgical, INC | $162.17 | 2023-2025 | |
| Sientra, INC. | $148.66 | 2020-2022 | |
| Acell, INC. | $104.73 | 2020 | |
| Smith+Nephew, INC. | $48.55 | 2019-2023 | Stravix |
| Kci USA, INC. | $42.68 | 2021-2022 | |
| Solventum Corporation | $35.25 | 2024 | Promogran Prisma, Activ.A.C., Prevena |
| Bioventus LLC | $22.85 | 2022 | |
| Baudax Bio INC. | $21.02 | 2022 | |
| Abbvie INC. | $20.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Abdollahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.